Malignancy, derived from the Latin male ("badly") and -gnus ("born"), refers to a medical condition characterized by progressive decline, especially in cancers, and marked by anaplasia, invasiveness, and metastasis. Historically, authors such as Lucius Duncan Bulkley described cancer as a departure from normal cellular function, emphasizing its invasive nature and its association with pernicious anemia.
Alexander Miles underlined the uncertainty between benign and malignant growths, stressing the significance of clinical context over histology alone. Alexis Thomson observed that a tumor’s malignancy can vary depending on its location and patient-related factors, while Oliver Wendell Holmes, Jr. discussed the therapeutic challenges involved in managing malignancy. These viewpoints highlight malignancy’s dual nature—as both a biological process and a complex clinical reality—shaped by anatomical, physiological, and treatment-related factors.